According to the Biocidal Products Regulation (BPR), prior to marketing your biocidal products in the EU, notification, registration and/or authorisation are required. The authorisation holder must be a legal entity based in one of the EU Member States. For UK based authorisation holders, after Brexit, in order to maintain the validity of your biocidal product authorisations, they must be transferred as a matter of priority to a legal entity established in the remaining EU 27 Member States, EEA countries or Switzerland by using the relevant case types in R4BP 3 (NA-TRS, SA-TRS or UA-TRS).
Please note that the transfers must be notified and implemented before the UK withdrawal. Similarly, all applicants should transfer, by using the transfer functionality embedded in the cases, all their ongoing R4BP 3 cases for which the prospective authorisation holder is a UK-based company.
At Kerona Scientific we have all the necessary skills, resources and experience to meet your Only Representative and Authorisation Transfer requirements.
Please send an email to email@example.com or contact our team on +353 1 849 5284 if you would like to discuss this further.